Peter B. Luppa

7.1k total citations · 3 hit papers
181 papers, 5.2k citations indexed

About

Peter B. Luppa is a scholar working on Molecular Biology, Endocrinology, Diabetes and Metabolism and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Peter B. Luppa has authored 181 papers receiving a total of 5.2k indexed citations (citations by other indexed papers that have themselves been cited), including 57 papers in Molecular Biology, 38 papers in Endocrinology, Diabetes and Metabolism and 23 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Peter B. Luppa's work include Monoclonal and Polyclonal Antibodies Research (21 papers), Hormonal and reproductive studies (18 papers) and Clinical Laboratory Practices and Quality Control (15 papers). Peter B. Luppa is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (21 papers), Hormonal and reproductive studies (18 papers) and Clinical Laboratory Practices and Quality Control (15 papers). Peter B. Luppa collaborates with scholars based in Germany, United States and United Kingdom. Peter B. Luppa's co-authors include Daniel W. Chan, Lori J. Sokoll, Jochen Metzger, H. Schlebusch, Sandeep Kumar Vashist, John H. T. Luong, Alice Schlichtiger, Carolin Müller, Aydogan Özcan and Leslie Y. Yeo and has published in prestigious journals such as Cell, Journal of Clinical Investigation and SHILAP Revista de lepidopterología.

In The Last Decade

Peter B. Luppa

175 papers receiving 5.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Emerging Technologies for Next-Generation Point-of-Care Testing

2015 528 citations Peter B. Luppa et al. profile →
Immunosensors—principles and applications to clinical chemistry

2001 512 citations Peter B. Luppa et al. profile →
Point-of-care testing (POCT): Current techniques and future perspectives

2011 455 citations Peter B. Luppa, H. Schlebusch et al. profile →

Peers

Countries citing papers authored by Peter B. Luppa

Since Specialization

Citations

This map shows the geographic impact of Peter B. Luppa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter B. Luppa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter B. Luppa more than expected).

Fields of papers citing papers by Peter B. Luppa

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter B. Luppa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter B. Luppa. The network helps show where Peter B. Luppa may publish in the future.

Co-authorship network of co-authors of Peter B. Luppa

This figure shows the co-authorship network connecting the top 25 collaborators of Peter B. Luppa. A scholar is included among the top collaborators of Peter B. Luppa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter B. Luppa. Peter B. Luppa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	The influence of undetected hemolysis on POCT potassium results in the emergency department 2024 ·Clinical Chemistry and Laboratory Medicine (CCLM) ·Andrei N. Tintu, Antonio Buño Soto, Viviane Van Hoof, Suzanne Bench, (unknown), (unknown), Kevin Rooney, Paloma Oliver, (unknown), Peter B. Luppa	0
2	SERS-based detection of the antibiotic ceftriaxone in spiked fresh plasma and microdialysate matrix by using silver-functionalized silicon nanowire substrates 2024 ·Talanta ·Chen Liu, (unknown), Susanne Weber, (unknown), (unknown), Long Wu, Edoardo Farnesi, Wenshu Zhang, Владимир Сиваков, Peter B. Luppa, Jürgen Popp, Dana Cialla‐May	13
3	Classification of “Near-patient” and “Point-of-Care” SARS-CoV-2 Nucleic Acid Amplification Test Systems and a first approach to evaluate their analytical independence of operator activities 2023 ·Journal of Clinical Virology ·Christoph Buchta, Heinz Zeichhardt, Tony Badrick, Wim Coucke, (unknown), Andrea Griesmacher, Stephan W. Aberle, Ingo Schellenberg, Ellis Jacobs, Gunnar Nordin, Christian Schweiger, (unknown), Peter B. Luppa, (unknown), Thomas Wagner, Martin Kammel	6
4	Rapid Diagnostic Platform for Personalized Vitamin B6 Detection in Erythrocytes via PLP Cofactor Mimics 2023 ·ACS Chemical Biology ·(unknown), (unknown), Ronny Schmidt, Peter B. Luppa, Nina C. Bach, Stephan A. Sieber	0
5	Surface plasmon resonance assays for the therapeutic drug monitoring of infliximab indicate clinical relevance of anti-infliximab antibody binding properties 2023 ·Clinical Chemistry and Laboratory Medicine (CCLM) ·(unknown), Susanne Weber, Matthias Treiber, Markus Thaler, Peter B. Luppa	4
6	Influence of diagnosis of venous thromboembolism on immature platelets, absolute platelet count and platelet aggregation over time 2020 ·Platelets ·(unknown), (unknown), Nicolas Langwieser, Bernhard Haller, Peter B. Luppa, Christian Bradaric, Dario Bongiovanni, Anja Stundl, Karl‐Ludwig Laugwitz, Tareq Ibrahim, Isabell Bernlochner	5
7	A lipid-binding loop of botulinum neurotoxin serotypes B, DC and G is an essential feature to confer their exquisite potency 2018 ·PLoS Pathogens ·Daniel Stern, Jasmin Weisemann, (unknown), (unknown), Stefan Mahrhold, Janett Piesker, Michael Laue, Peter B. Luppa, Martin B. Dorner, Brigitte G. Dorner, Andreas Rummel	27
8	Hyperkalemia in patients treated with endoradiotherapy combined with amino acid infusion is associated with severe metabolic acidosis 2018 ·EJNMMI Research ·Christian H. Pfob, Matthias Eiber, Peter B. Luppa, (unknown), Tobias Maurer, Robert Tauber, Calogero D’Alessandria, Benedikt Feuerecker, Klemens Scheidhauer, Armin Ott, Uwe Heemann, Markus Schwaiger, Christoph Schmaderer	4
9	Mammographic Density and Vitamin D Levels – A Cross-sectional Study 2017 ·Geburtshilfe und Frauenheilkunde ·Loreen Straub, (unknown), Peter B. Luppa, (unknown), (unknown), Marion Kiechle, Vanadin Seifert‐Klauss	6
10	Influence of high-flux hemodialysis and hemodiafiltration on serum C-terminal agrin fragment levels in end-stage renal disease patients 2014 ·Translational research ·Dominik Steubl, Stefan Hettwer, Pius Dahinden, Petra Wolf, Peter B. Luppa, Carsten A. Wagner, Claudius Küchle, Christoph Schmaderer, Lutz Renders, Uwe Heemann, Marcel Roos	7
11	C-terminal agrin fragment (CAF) as a serum biomarker for residual renal function in peritoneal dialysis patients 2014 ·International Urology and Nephrology ·Dominik Steubl, Stefan Hettwer, Pius Dahinden, Peter B. Luppa, Ina‐Christine Rondak, Christina Regenbogen, Konrad Stock, Lutz Renders, Uwe Heemann, Marcel Roos	16
12	A new strategy for the development of monoclonal antibodies for the determination of human procalcitonin in serum samples 2011 ·Analytical and Bioanalytical Chemistry ·Elisabeth Kremmer, Kathleen Meyer, Friedrich A. Grässer, Andrew Flatley, (unknown), Peter B. Luppa, Peter Krämer	23
13	Patientennahe Labordiagnostik. Point‐of‐Care‐Testing 2009 ·Chemie in unserer Zeit ·Günter Gauglitz, Peter B. Luppa	9
14	Venlafaxine and mirtazapine treatment lowers serum concentrations of dehydroepiandrosterone-sulfate in depressed patients remitting during the course of treatment 2009 ·Journal of Psychiatric Research ·Georgios Paslakis, Peter B. Luppa, Maria Gilles, Daniel Kopf, (unknown), Florian Lederbogen, Michael Deuschle	15
15	CpG motif‐independent activation of TLR9 upon endosomal translocation of “natural” phosphodiester DNA 2006 ·European Journal of Immunology ·Kei Yasuda, Mark Rutz, (unknown), Jochen Metzger, Peter B. Luppa, Frank Schmitz, Tobias Haas, Antje Heit, Stefan Bauer, Hermann Wagner	96
16	Unchanged androgen-binding properties of sex hormone-binding globulin in male patients with liver cirrhosis 2006 ·Clinical Chemistry and Laboratory Medicine (CCLM) ·Peter B. Luppa, Markus Thaler, Ewert Schulte‐Frohlinde, (unknown), (unknown), Jochen Metzger	18
17	Role of Endocytosis in Cellular Uptake of Sex Steroids 2005 ·Cell ·Annette Hammes, Thomas K. Andreassen, Robert Spoelgen, Jens Raila, Norbert Hübner, Herbert Schulz, Jochen Metzger, Florian J. Schweigert�, Peter B. Luppa, Anders Nykjær, Thomas E. Willnow	299
18	Multicenter evaluation of the analytical and clinical performance of the Elecsys ® S100 immunoassay in patients with malignant melanoma 2005 ·Clinical Chemistry and Laboratory Medicine (CCLM) ·(unknown), Rüdiger Hein, Claus Garbe, Ulrich M. Caroli, Peter B. Luppa	22
19	Patientennahe Laboratoriumsdiagnostik (Point-of-Care-Testing): Empfehlungen zum Einsatz von unterschiedlichem Probenmaterial für die Diagnostik des Diabetes mellitus / Bedside testing in laboratory diagnostics (point-of-care testing): recommendations for the use of different testing materials in the diagnostics of Diabetes mellitus 2004 ·LaboratoriumsMedizin ·Rainer Haeckel, (unknown), Theodor Koschinsky, Peter B. Luppa, H. Schlebusch, Hans Günther Wahl	2
20	Application of ion-pair high-performance liquid chromatography to detection of the atypical coproporphyrin isomers II and IV in human faeces 1991 ·Journal of Chromatography B Biomedical Sciences and Applications ·K. Jacob, (unknown), (unknown), D. Neumeier, Peter B. Luppa	4

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact